NZ Research Finds Anticholesteral Drug May Modify Stroke Risk

Pravastatin, a drug used to help lower blood cholesterol levels, may have a role to play in stroke prevention according to research (published in The New England Journal of Medicine) led by Dr Harvey D. White of Greenlane Hospital, Auckland, New Zealand, and a multi-centre team of researchers.


Tags: Auckland  cholesterol drug  Fox News  Greenlane hospital  Harvey D. White (Dr)  Medical Health  New Zealand  Pravastatin  The New England Journal of Medicine  

Former Equinox Head Sarah Robb O’Hagan in New Role

Former Equinox Head Sarah Robb O’Hagan in New Role

Former Equinox president New Zealander Sarah Robb O’Hagan, who has been advising fitness brand Exos’ board since September of last year, will take the reins as chief executive officer, Fast Company…